Literature DB >> 3434334

Role of electroconvulsive therapy in neuroleptic malignant syndrome (NMS)

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3434334     DOI： 10.1111/j.1600-0447.1987.tb02927.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN： 0001-690X            Impact factor:   6.392


× No keyword cloud information.
  2 in total

1.  Neuroleptic malignant syndrome: a preventive program.

Authors:  M L Fernando; R Manchanda; C Kirk
Journal:  J Psychiatry Neurosci       Date:  1992-03       Impact factor: 6.186

Review 2.  The Nonclinical Safety Profile of GalNAc-conjugated RNAi Therapeutics in Subacute Studies.

Authors:  Maja M Janas; Carole E Harbison; Victoria K Perry; Brenda Carito; Jessica E Sutherland; Akshay K Vaishnaw; Natalie D Keirstead; Garvin Warner
Journal:  Toxicol Pathol       Date:  2018-08-23       Impact factor: 1.902
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.